Hana Pharm Co Ltd Capital Reinvestment Ratio
Hana Pharm Co Ltd capital reinvestment ratio. Hana Pharm Co Ltd (293480) has a Capital Reinvestment Ratio of 2.55x as of June 2026, meaning it reinvests 3% of its operating cash flow (₩6.91 Billion) in capital expenditures (₩17.59 Billion). Check total reinvestment intensity of Hana Pharm Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Hana Pharm Co Ltd (2016–2025)
Capital reinvestment ratio of Hana Pharm Co Ltd from 2016 to 2025. This chart tracks Hana Pharm Co Ltd's Capital Reinvestment Ratio across 10 annual periods. Also explore Hana Pharm Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Hana Pharm Co Ltd Capital Reinvestment Ratio by Year (2016–2025)
Hana Pharm Co Ltd capital reinvestment ratio by year from 2016 to 2025. For the full cash flow conversion analysis, see Hana Pharm Co Ltd operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 3.40x | ₩9.18 Billion | ₩31.18 Billion | ▲ +550.9% |
| 2024 | 0.52x | ₩25.30 Billion | ₩13.21 Billion | ▼ -34.6% |
| 2023 | 0.80x | ₩18.40 Billion | ₩14.68 Billion | ▼ -31.1% |
| 2022 | 1.16x | ₩30.88 Billion | ₩35.77 Billion | ▼ -14.6% |
| 2021 | 1.36x | ₩25.66 Billion | ₩34.81 Billion | ▲ +23.3% |
| 2020 | 1.10x | ₩15.58 Billion | ₩17.14 Billion | ▲ +3.4% |
| 2019 | 1.06x | ₩31.72 Billion | ₩33.73 Billion | ▲ +426.7% |
| 2018 | 0.20x | ₩27.59 Billion | ₩5.57 Billion | ▼ -49.7% |
| 2017 | 0.40x | ₩25.38 Billion | ₩10.19 Billion | ▼ -39.8% |
| 2016 | 0.67x | ₩12.46 Billion | ₩8.31 Billion | — |